$40.000
+0.436 (+1.09%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
GMAB 相似圖表分析預測
Alphio's GMAB stock price prediction model matches the current Genmab A/S tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $39.99 (-0.03%). The 1-week path is $40.11 (+0.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Genmab A/S 股票嗎？
Genmab A/S (GMAB) is a good buy right now due to its current price of $37, which is significantly below the average analyst price target of $50, indicating a potential upside of 35%. Additionally, the company has demonstrated strong financial performance with a gross margin of 92.73% in Q2 2026, showcasing its efficiency and profitability. However, the main risk is the recent failure of the Epcoritamab trial, which could impact future sales expectations and market acceptance.
GMAB 股價於 Thursday 收在 $40.00，此前上漲 +1.09%
Genmab A/S (GMAB) last closed at $40, gaining +1.09%. These facts feed the 1-day and 1-week GMAB price prediction above.
預測驅動因素
Genmab A/S（GMAB）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 GMAB 最接近的股票，依相似度排序。
GMAB 季節性分析
Historically the probability of a positive October return for GMAB is 62.90%. September offers the highest probability of a positive month at 67.74%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
GMAB 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Oct 2026 | $17.30 | $21.62 | $22.57 | -45.94% |
| Nov 2026 | $28.07 | $28.69 | $33.47 | -28.27% |
| Dec 2026 | $24.17 | $24.45 | $26.55 | -38.88% |
2026 年，Genmab A/S（GMAB）預計區間為 $17.30 至 $33.47。
Genmab A/S 2026 年月度預測
2026 年 Oct，Genmab A/S 預計均價 $21.62，最低 $17.30，最高 $22.57。
2026 年 Nov，Genmab A/S 預計均價 $28.69，最低 $28.07，最高 $33.47。
2026 年 Dec，Genmab A/S 預計均價 $24.45，最低 $24.17，最高 $26.55。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。